Kevin M. Barry
|
CFO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
18,727 |
0
|
-
|
|
-
|
Stock Option |
Kevin M. Pohlman
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Apr 2025 |
18,040 |
185,961
(0%)
|
0%
|
|
0
|
Common Stock |
Kevin M. Pohlman
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Apr 2025 |
31,146 |
217,107
(0%)
|
0%
|
|
0
|
Common Stock |
Kevin M. Pohlman
|
Chief Operating Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
217,107 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
Kevin M. Pohlman
|
Chief Operating Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
1,923 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
Kevin M. Pohlman
|
Chief Operating Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
28,090 |
0
|
-
|
|
-
|
Stock Option |
Kevin M. Pohlman
|
Chief Operating Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
18,300 |
0
|
-
|
|
-
|
Stock Option |
Kevin M. Pohlman
|
Chief Operating Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
18,916 |
0
|
-
|
|
-
|
Stock Option |
Kevin M. Pohlman
|
Chief Operating Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
24,780 |
0
|
-
|
|
-
|
Stock Option |
Kevin M. Pohlman
|
Chief Operating Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
33,784 |
0
|
-
|
|
-
|
Stock Option |
Kevin M. Pohlman
|
Chief Operating Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
5,539 |
0
|
-
|
|
-
|
Stock Option |
Kevin M. Pohlman
|
Chief Operating Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
13,935 |
0
|
-
|
|
-
|
Stock Option |
Philip G.J. McKoy
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
18,114 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
Kevin M. Barry
|
CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Apr 2025 |
4,577 |
45,375
(0%)
|
0%
|
|
0
|
Common Stock |
Kevin M. Barry
|
CFO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
7,881 |
0
|
-
|
|
-
|
Stock Option |
Kevin M. Barry
|
CFO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
7,883 |
0
|
-
|
|
-
|
Stock Option |
Kevin M. Pohlman
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Apr 2025 |
10,624 |
167,921
(0%)
|
0%
|
|
0
|
Common Stock |
Kevin M. Barry
|
CFO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
1,676 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
Kevin M. Barry
|
CFO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
77,127 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
Kevin M. Barry
|
CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Apr 2025 |
19,726 |
77,127
(0%)
|
0%
|
|
0
|
Common Stock |
Kevin M. Barry
|
CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Apr 2025 |
12,026 |
57,401
(0%)
|
0%
|
|
0
|
Common Stock |
Kevin M. Barry
|
CFO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
12,392 |
0
|
-
|
|
-
|
Stock Option |
Kevin M. Barry
|
CFO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
30,030 |
0
|
-
|
|
-
|
Stock Option |
Kevin M. Barry
|
CFO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
11,013 |
0
|
-
|
|
-
|
Stock Option |
Samantha L. Bergeson
|
CHRO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Apr 2025 |
5,186 |
25,773
(0%)
|
0%
|
|
0
|
Common Stock |
Samantha L. Bergeson
|
CHRO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
35,117 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
Samantha L. Bergeson
|
CHRO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Apr 2025 |
9,344 |
35,117
(0%)
|
0%
|
|
0
|
Common Stock |
Samantha L. Bergeson
|
CHRO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
998 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
Samantha L. Bergeson
|
CHRO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
8,076 |
0
|
-
|
|
-
|
Stock Option |
Meenu Agarwal
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
12,788 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
Pamela J. Tomczik
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
7,820 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
Les B. Korsh
|
CLO & Corporate Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Apr 2025 |
9,807 |
112,520
(0%)
|
0%
|
|
0
|
Common Stock |
Donald J. Zurbay
|
Director, President & CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
398,185 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
Donald J. Zurbay
|
Director, President & CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
33,363 |
0
|
-
|
|
-
|
Stock Option |
Donald J. Zurbay
|
Director, President & CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
78,829 |
0
|
-
|
|
-
|
Stock Option |
Donald J. Zurbay
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Apr 2025 |
20,840 |
243,576
(0%)
|
0%
|
|
0
|
Common Stock |
Donald J. Zurbay
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Apr 2025 |
60,132 |
303,708
(0%)
|
0%
|
|
0
|
Common Stock |
Donald J. Zurbay
|
Director, President & CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
99,250 |
0
|
-
|
|
-
|
Stock Option |
Donald J. Zurbay
|
Director, President & CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
35,895 |
0
|
-
|
|
-
|
Stock Option |
Donald J. Zurbay
|
Director, President & CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
134,033 |
0
|
-
|
|
-
|
Stock Option |
Donald J. Zurbay
|
Director, President & CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
93,633 |
0
|
-
|
|
-
|
Stock Option |
Jody H. Feragen
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
56,145 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
John D. Buck
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
92,869 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
Neil A. Schrimsher
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
48,788 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
Alex N. Blanco
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
41,300 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
Les B. Korsh
|
CLO & Corporate Secretary |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
25,749 |
0
|
-
|
|
-
|
Stock Option |
Donald J. Zurbay
|
Director, President & CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
1,243 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
Les B. Korsh
|
CLO & Corporate Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Apr 2025 |
16,536 |
129,056
(0%)
|
0%
|
|
0
|
Common Stock |
Les B. Korsh
|
CLO & Corporate Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Apr 2025 |
24,917 |
153,973
(0%)
|
0%
|
|
0
|
Common Stock |
Les B. Korsh
|
CLO & Corporate Secretary |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
153,973 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
Les B. Korsh
|
CLO & Corporate Secretary |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
2,283 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
Les B. Korsh
|
CLO & Corporate Secretary |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
16,892 |
0
|
-
|
|
-
|
Stock Option |
Les B. Korsh
|
CLO & Corporate Secretary |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
17,339 |
0
|
-
|
|
-
|
Stock Option |
Les B. Korsh
|
CLO & Corporate Secretary |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
24,780 |
0
|
-
|
|
-
|
Stock Option |
Les B. Korsh
|
CLO & Corporate Secretary |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
33,784 |
0
|
-
|
|
-
|
Stock Option |
Les B. Korsh
|
CLO & Corporate Secretary |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
14,179 |
0
|
-
|
|
-
|
Stock Option |
Les B. Korsh
|
CLO & Corporate Secretary |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
11,845 |
0
|
-
|
|
-
|
Stock Option |
Les B. Korsh
|
CLO & Corporate Secretary |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
10,379 |
0
|
-
|
|
-
|
Stock Option |
Les B. Korsh
|
CLO & Corporate Secretary |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
25,000 |
0
|
-
|
|
-
|
Stock Option |
Robert C. Frenzel
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
38,242 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
Kevin M. Pohlman
|
Chief Operating Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
13,345 |
0
|
-
|
|
-
|
Stock Option |
Donald J. Zurbay
|
Director, President & CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
57,819 |
0
|
-
|
|
-
|
Stock Option |
Donald J. Zurbay
|
Director, President & CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Apr 2025 |
37,831 |
0
|
-
|
|
-
|
Stock Option |
Donald J. Zurbay
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Apr 2025 |
94,477 |
398,185
(0%)
|
0%
|
|
0
|
Common Stock |
Kevin M. Pohlman
|
Chief Operating Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.08 per share. |
13 Dec 2024 |
420 |
157,297
(0%)
|
0%
|
31.1 |
13,054
|
Common Stock |
Kevin M. Barry
|
CFO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.08 per share. |
13 Dec 2024 |
807 |
40,798
(0%)
|
0%
|
31.1 |
25,082
|
Common Stock |
Donald J. Zurbay
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 23.08 per share. |
05 Dec 2024 |
1,962 |
222,736
(0%)
|
0%
|
23.1 |
45,278
|
Common Stock |
Donald J. Zurbay
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.83 per share. |
05 Dec 2024 |
5,374 |
224,698
(0%)
|
0%
|
22.8 |
122,688
|
Common Stock |
Les B. Korsh
|
CLO & Corporate Secretary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.76 per share. |
12 Nov 2024 |
1,052 |
102,713
(0%)
|
0%
|
20.8 |
21,840
|
Common Stock |
Kevin M. Pohlman
|
Chief Operating Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.76 per share. |
12 Nov 2024 |
939 |
157,717
(0%)
|
0%
|
20.8 |
19,494
|
Common Stock |
Samantha L. Bergeson
|
CHRO |
Grant, award, or other acquisition of securities at price $ 18.56 per share. |
30 Sep 2024 |
9 |
20,587
(0%)
|
0%
|
18.6 |
167
|
Common Stock |
Jody H. Feragen
|
Director |
Grant, award, or other acquisition of securities at price $ 21.74 per share. |
16 Sep 2024 |
7,820 |
57,145
(0%)
|
0%
|
21.7 |
170,007
|
Common Stock |
John D. Buck
|
Director |
Grant, award, or other acquisition of securities at price $ 21.74 per share. |
16 Sep 2024 |
7,820 |
92,869
(0%)
|
0%
|
21.7 |
170,007
|
Common Stock |
Neil A. Schrimsher
|
Director |
Grant, award, or other acquisition of securities at price $ 21.74 per share. |
16 Sep 2024 |
7,820 |
48,788
(0%)
|
0%
|
21.7 |
170,007
|
Common Stock |
Alex N. Blanco
|
Director |
Grant, award, or other acquisition of securities at price $ 21.74 per share. |
16 Sep 2024 |
7,820 |
41,300
(0%)
|
0%
|
21.7 |
170,007
|
Common Stock |
Robert C. Frenzel
|
Director |
Grant, award, or other acquisition of securities at price $ 21.74 per share. |
16 Sep 2024 |
7,820 |
38,242
(0%)
|
0%
|
21.7 |
170,007
|
Common Stock |
Philip G.J. McKoy
|
Director |
Grant, award, or other acquisition of securities at price $ 21.74 per share. |
16 Sep 2024 |
7,820 |
18,114
(0%)
|
0%
|
21.7 |
170,007
|
Common Stock |
Meenu Agarwal
|
Director |
Grant, award, or other acquisition of securities at price $ 21.74 per share. |
16 Sep 2024 |
7,820 |
12,788
(0%)
|
0%
|
21.7 |
170,007
|
Common Stock |
Pamela J. Tomczik
|
Director |
Grant, award, or other acquisition of securities at price $ 21.74 per share. |
16 Sep 2024 |
7,820 |
7,820
(0%)
|
0%
|
21.7 |
170,007
|
Common Stock |
Donald J. Zurbay
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 24.99 per share. |
16 Jul 2024 |
7,216 |
230,072
(0%)
|
0%
|
25.0 |
180,328
|
Common Stock |
Donald J. Zurbay
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 23.71 per share. |
03 Jul 2024 |
5,875 |
237,288
(0%)
|
0%
|
23.7 |
139,322
|
Common Stock |
Les B. Korsh
|
CLO & Corporate Secretary |
Sale of securities on an exchange or to another person at price $ 23.71 per share. |
03 Jul 2024 |
2,842 |
103,765
(0%)
|
0%
|
23.7 |
67,398
|
Common Stock |
Kevin M. Barry
|
CFO |
Sale of securities on an exchange or to another person at price $ 23.72 per share. |
03 Jul 2024 |
1,216 |
41,605
(0%)
|
0%
|
23.7 |
28,846
|
Common Stock |
Samantha L. Bergeson
|
CHRO |
Sale of securities on an exchange or to another person at price $ 23.87 per share. |
03 Jul 2024 |
254 |
20,578
(0%)
|
0%
|
23.9 |
6,063
|
Common Stock |
Donald J. Zurbay
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.08 per share. |
01 Jul 2024 |
4,322 |
137,601
(0%)
|
0%
|
24.1 |
104,074
|
Common Stock |
Donald J. Zurbay
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 24.08 per share. |
01 Jul 2024 |
94,477 |
243,163
(0%)
|
0%
|
24.1 |
2,275,006
|
Common Stock |
Donald J. Zurbay
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.08 per share. |
01 Jul 2024 |
4,888 |
148,686
(0%)
|
0%
|
24.1 |
117,703
|
Common Stock |
Donald J. Zurbay
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 24.08 per share. |
01 Jul 2024 |
15,973 |
153,574
(0%)
|
0%
|
24.1 |
384,630
|
Common Stock |
Les B. Korsh
|
CLO & Corporate Secretary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.08 per share. |
01 Jul 2024 |
2,241 |
81,690
(0%)
|
0%
|
24.1 |
53,963
|
Common Stock |
Les B. Korsh
|
CLO & Corporate Secretary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.08 per share. |
01 Jul 2024 |
1,485 |
76,610
(0%)
|
0%
|
24.1 |
35,759
|
Common Stock |
Les B. Korsh
|
CLO & Corporate Secretary |
Grant, award, or other acquisition of securities at price $ 24.08 per share. |
01 Jul 2024 |
7,321 |
83,931
(0%)
|
0%
|
24.1 |
176,290
|
Common Stock |
Les B. Korsh
|
CLO & Corporate Secretary |
Grant, award, or other acquisition of securities at price $ 24.08 per share. |
01 Jul 2024 |
24,917 |
106,607
(0%)
|
0%
|
24.1 |
600,001
|
Common Stock |
Kevin M. Pohlman
|
Chief Operating Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.08 per share. |
01 Jul 2024 |
970 |
121,468
(0%)
|
0%
|
24.1 |
23,358
|
Common Stock |
Kevin M. Pohlman
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 24.08 per share. |
01 Jul 2024 |
7,987 |
129,455
(0%)
|
0%
|
24.1 |
192,327
|
Common Stock |
Kevin M. Pohlman
|
Chief Operating Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.08 per share. |
01 Jul 2024 |
1,945 |
127,510
(0%)
|
0%
|
24.1 |
46,836
|
Common Stock |
Kevin M. Pohlman
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 24.08 per share. |
01 Jul 2024 |
31,146 |
158,656
(0%)
|
0%
|
24.1 |
749,996
|
Common Stock |
Kevin M. Barry
|
CFO |
Grant, award, or other acquisition of securities at price $ 24.08 per share. |
01 Jul 2024 |
19,726 |
42,821
(0%)
|
0%
|
24.1 |
475,002
|
Common Stock |
Kevin M. Barry
|
CFO |
Grant, award, or other acquisition of securities at price $ 24.08 per share. |
01 Jul 2024 |
3,328 |
24,114
(0%)
|
0%
|
24.1 |
80,138
|
Common Stock |
Kevin M. Barry
|
CFO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.08 per share. |
01 Jul 2024 |
888 |
20,786
(0%)
|
0%
|
24.1 |
21,383
|
Common Stock |
Kevin M. Barry
|
CFO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.08 per share. |
01 Jul 2024 |
1,019 |
23,095
(0%)
|
0%
|
24.1 |
24,538
|
Common Stock |
Samantha L. Bergeson
|
CHRO |
Grant, award, or other acquisition of securities at price $ 24.08 per share. |
01 Jul 2024 |
9,344 |
20,832
(0%)
|
0%
|
24.1 |
225,004
|
Common Stock |
Samantha L. Bergeson
|
CHRO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.08 per share. |
01 Jul 2024 |
571 |
11,488
(0%)
|
0%
|
24.1 |
13,750
|
Common Stock |
Samantha L. Bergeson
|
CHRO |
Grant, award, or other acquisition of securities at price $ 20.50 per share. |
30 Jun 2024 |
427 |
12,059
(0%)
|
0%
|
20.5 |
8,754
|
Common Stock |
Samantha L. Bergeson
|
CHRO |
Grant, award, or other acquisition of securities at price $ 23.50 per share. |
31 Mar 2024 |
436 |
11,632
(0%)
|
0%
|
23.5 |
10,247
|
Common Stock |
M. Kevin Pohlman
|
Chief Operating Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.00 per share. |
15 Dec 2023 |
996 |
122,438
(0%)
|
0%
|
27 |
26,892
|
Common Stock |
Barry Kevin M.
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.00 per share. |
15 Dec 2023 |
869 |
22,234
(0%)
|
0%
|
27 |
23,463
|
Common Stock |
Barry Kevin M.
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 27.18 per share. |
15 Dec 2023 |
560 |
21,674
(0%)
|
0%
|
27.2 |
15,221
|
Common Stock |
Zurbay Donald J.
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.59 per share. |
05 Dec 2023 |
5,748 |
143,791
(0%)
|
0%
|
26.6 |
152,839
|
Common Stock |
Donald Zurbay J.
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 26.58 per share. |
05 Dec 2023 |
1,868 |
141,923
(0%)
|
0%
|
26.6 |
49,651
|
Common Stock |
Barry Kevin M.
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 25.36 per share. |
01 Dec 2023 |
1,627 |
23,103
(0%)
|
0%
|
25.4 |
41,261
|
Common Stock |
Kevin M. Pohlman
|
Chief Operating Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.02 per share. |
14 Nov 2023 |
538 |
123,434
(0%)
|
0%
|
32.0 |
17,227
|
Common Stock |
Timothy E. Rogan
|
President - Dental |
Sale of securities on an exchange or to another person at price $ 29.75 per share. |
05 Oct 2023 |
9,260 |
40,382
(0%)
|
0%
|
29.8 |
275,525
|
Common Stock |
Samantha L. Bergeson
|
CHRO |
Grant, award, or other acquisition of securities at price $ 23.69 per share. |
30 Sep 2023 |
422 |
11,196
(0%)
|
0%
|
23.7 |
9,997
|
Common Stock |
Ellen A. Rudnick
|
Director |
Grant, award, or other acquisition of securities at price $ 29.19 per share. |
11 Sep 2023 |
4,968 |
75,715
(0%)
|
0%
|
29.2 |
145,016
|
Common Stock |
Jody H. Feragen
|
Director |
Grant, award, or other acquisition of securities at price $ 29.19 per share. |
11 Sep 2023 |
4,968 |
49,325
(0%)
|
0%
|
29.2 |
145,016
|
Common Stock |
John D. Buck
|
Director |
Grant, award, or other acquisition of securities at price $ 29.19 per share. |
11 Sep 2023 |
4,968 |
85,049
(0%)
|
0%
|
29.2 |
145,016
|
Common Stock |
Neil A. Schrimsher
|
Director |
Grant, award, or other acquisition of securities at price $ 29.19 per share. |
11 Sep 2023 |
4,968 |
40,968
(0%)
|
0%
|
29.2 |
145,016
|
Common Stock |
Alex N. Blanco
|
Director |
Grant, award, or other acquisition of securities at price $ 29.19 per share. |
11 Sep 2023 |
4,968 |
33,480
(0%)
|
0%
|
29.2 |
145,016
|
Common Stock |
Robert C. Frenzel
|
Director |
Grant, award, or other acquisition of securities at price $ 29.19 per share. |
11 Sep 2023 |
4,968 |
30,422
(0%)
|
0%
|
29.2 |
145,016
|
Common Stock |
Philip G.J. McKoy
|
Director |
Grant, award, or other acquisition of securities at price $ 29.19 per share. |
11 Sep 2023 |
4,968 |
10,294
(0%)
|
0%
|
29.2 |
145,016
|
Common Stock |
Meenu Agarwal
|
Director |
Grant, award, or other acquisition of securities at price $ 29.19 per share. |
11 Sep 2023 |
4,968 |
4,968
(0%)
|
0%
|
29.2 |
145,016
|
Common Stock |
Timothy E. Rogan
|
President - Dental |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.46 per share. |
19 Jul 2023 |
201 |
49,642
(0%)
|
0%
|
32.5 |
6,524
|
Common Stock |
Timothy E. Rogan
|
President - Dental |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.46 per share. |
19 Jul 2023 |
760 |
40,642
(0%)
|
0%
|
32.5 |
24,670
|
Common Stock |
Donald J. Zurbay
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 32.48 per share. |
18 Jul 2023 |
5,620 |
149,539
(0%)
|
0%
|
32.5 |
182,553
|
Common Stock |
Les B. Korsh
|
CLO & Corporate Secretary |
Sale of securities on an exchange or to another person at price $ 32.47 per share. |
18 Jul 2023 |
3,686 |
78,095
(0%)
|
0%
|
32.5 |
119,686
|
Common Stock |
Donald J. Zurbay
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.07 per share. |
14 Jul 2023 |
4,490 |
139,329
(0%)
|
0%
|
32.1 |
143,994
|
Common Stock |
Donald J. Zurbay
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 32.07 per share. |
14 Jul 2023 |
28,867 |
168,196
(0%)
|
0%
|
32.1 |
925,765
|
Common Stock |
Donald J. Zurbay
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.07 per share. |
14 Jul 2023 |
13,037 |
155,159
(0%)
|
0%
|
32.1 |
418,097
|
Common Stock |
Les B. Korsh
|
CLO & Corporate Secretary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.07 per share. |
14 Jul 2023 |
1,139 |
73,126
(0%)
|
0%
|
32.1 |
36,528
|
Common Stock |
Les B. Korsh
|
CLO & Corporate Secretary |
Grant, award, or other acquisition of securities at price $ 32.07 per share. |
14 Jul 2023 |
12,374 |
85,500
(0%)
|
0%
|
32.1 |
396,834
|
Common Stock |
Les B. Korsh
|
CLO & Corporate Secretary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.07 per share. |
14 Jul 2023 |
3,719 |
81,781
(0%)
|
0%
|
32.1 |
119,268
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.07 per share. |
14 Jul 2023 |
2,942 |
123,972
(0%)
|
0%
|
32.1 |
94,350
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 32.07 per share. |
14 Jul 2023 |
12,374 |
126,914
(0%)
|
0%
|
32.1 |
396,834
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.07 per share. |
14 Jul 2023 |
674 |
114,540
(0%)
|
0%
|
32.1 |
21,615
|
Common Stock |
Timothy E. Rogan
|
President - Dental |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.07 per share. |
14 Jul 2023 |
760 |
49,843
(0%)
|
0%
|
32.1 |
24,373
|
Common Stock |
Kevin Barry
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.07 per share. |
14 Jul 2023 |
506 |
20,883
(0%)
|
0%
|
32.1 |
16,227
|
Common Stock |
Kevin Barry
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 32.07 per share. |
14 Jul 2023 |
5,501 |
26,384
(0%)
|
0%
|
32.1 |
176,417
|
Common Stock |
Kevin Barry
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.07 per share. |
14 Jul 2023 |
1,654 |
24,730
(0%)
|
0%
|
32.1 |
53,044
|
Common Stock |
Samantha L. Bergeson
|
CHRO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.07 per share. |
14 Jul 2023 |
134 |
10,774
(0%)
|
0%
|
32.1 |
4,297
|
Common Stock |
Donald J. Zurbay
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 32.34 per share. |
05 Jul 2023 |
1,666 |
143,819
(0%)
|
0%
|
32.3 |
53,878
|
Common Stock |
Les B. Korsh
|
CLO & Corporate Secretary |
Sale of securities on an exchange or to another person at price $ 32.34 per share. |
05 Jul 2023 |
908 |
74,265
(0%)
|
0%
|
32.3 |
29,365
|
Common Stock |
Timothy E. Rogan
|
President - Dental |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.26 per share. |
05 Jul 2023 |
586 |
44,966
(0%)
|
0%
|
33.3 |
19,490
|
Common Stock |
Timothy E. Rogan
|
President - Dental |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Jul 2023 |
17,556 |
17,556
|
-
|
|
-
|
Employee Stock Options |
Timothy E. Rogan
|
President - Dental |
Grant, award, or other acquisition of securities at price $ 33.26 per share. |
05 Jul 2023 |
5,637 |
50,603
(0%)
|
0%
|
33.3 |
187,487
|
Common Stock |
Donald J. Zurbay
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 33.26 per share. |
01 Jul 2023 |
30,066 |
145,485
(0%)
|
0%
|
33.3 |
999,995
|
Common Stock |
Donald J. Zurbay
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.26 per share. |
01 Jul 2023 |
2,282 |
115,419
(0%)
|
0%
|
33.3 |
75,899
|
Common Stock |
Donald J. Zurbay
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2023 |
93,633 |
93,633
|
-
|
|
-
|
Employee Stock Options |
Les B. Korsh
|
CLO & Corporate Secretary |
Grant, award, or other acquisition of securities at price $ 33.26 per share. |
01 Jul 2023 |
8,268 |
75,173
(0%)
|
0%
|
33.3 |
274,994
|
Common Stock |
Les B. Korsh
|
CLO & Corporate Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2023 |
25,749 |
25,749
|
-
|
|
-
|
Employee Stock Options |
Les B. Korsh
|
CLO & Corporate Secretary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.26 per share. |
01 Jul 2023 |
1,044 |
66,905
(0%)
|
0%
|
33.3 |
34,723
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.26 per share. |
01 Jul 2023 |
701 |
106,336
(0%)
|
0%
|
33.3 |
23,315
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 33.26 per share. |
01 Jul 2023 |
9,020 |
115,356
(0%)
|
0%
|
33.3 |
300,005
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2023 |
28,090 |
28,090
|
-
|
|
-
|
Employee Stock Options |
Kevin Barry
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2023 |
18,727 |
18,727
|
-
|
|
-
|
Employee Stock Options |
Kevin Barry
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 33.26 per share. |
01 Jul 2023 |
6,013 |
21,389
(0%)
|
0%
|
33.3 |
199,992
|
Common Stock |
Kevin Barry
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.26 per share. |
01 Jul 2023 |
395 |
15,376
(0%)
|
0%
|
33.3 |
13,138
|
Common Stock |
Samantha L. Bergeson
|
CHRO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.26 per share. |
01 Jul 2023 |
467 |
8,315
(0%)
|
0%
|
33.3 |
15,532
|
Common Stock |
Samantha L. Bergeson
|
CHRO |
Grant, award, or other acquisition of securities at price $ 33.26 per share. |
01 Jul 2023 |
2,593 |
10,908
(0%)
|
0%
|
33.3 |
86,243
|
Common Stock |
Samantha L. Bergeson
|
CHRO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2023 |
8,076 |
8,076
|
-
|
|
-
|
Employee Stock Option |
Samantha L. Bergeson
|
CHRO |
Grant, award, or other acquisition of securities at price $ 23.69 per share. |
30 Jun 2023 |
247 |
8,782
(0%)
|
0%
|
23.7 |
5,851
|
Common Stock |
Les B. Korsh
|
CLO & Corporate Secretary |
Sale of securities on an exchange or to another person at price $ 31.75 per share. |
21 Jun 2023 |
3,500 |
67,949
(0%)
|
0%
|
31.8 |
111,125
|
Common Stock |
Jody H. Feragen
|
Director |
|
29 Apr 2023 |
1,000 |
56,145
(0%)
|
0%
|
31.1 |
31,066
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 27.87 per share. |
15 Dec 2022 |
8,073 |
107,418
(0%)
|
0%
|
27.9 |
224,995
|
Common Stock |
Kevin Barry
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 27.87 per share. |
15 Dec 2022 |
9,329 |
15,771
(0%)
|
0%
|
27.9 |
259,999
|
Common Stock |
Donald J. Zurbay
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Dec 2022 |
134,033 |
134,033
|
-
|
|
-
|
Employee Stock Options |
Donald J. Zurbay
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 28.99 per share. |
05 Dec 2022 |
39,669 |
117,701
(0%)
|
0%
|
29.0 |
1,150,004
|
Common Stock |
Kevin Barry
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 29.10 per share. |
05 Dec 2022 |
9,443 |
6,442
(0%)
|
0%
|
29.1 |
274,808
|
Common Stock |
Ellen A. Rudnick
|
Director |
Grant, award, or other acquisition of securities at price $ 27.23 per share. |
12 Sep 2022 |
5,326 |
70,747
(0%)
|
0%
|
27.2 |
145,027
|
Common Stock |
Jody H. Feragen
|
Director |
Grant, award, or other acquisition of securities at price $ 27.23 per share. |
12 Sep 2022 |
5,326 |
44,357
(0%)
|
0%
|
27.2 |
145,027
|
Common Stock |
John D. Buck
|
Director |
Grant, award, or other acquisition of securities at price $ 27.23 per share. |
12 Sep 2022 |
5,326 |
80,081
(0%)
|
0%
|
27.2 |
145,027
|
Common Stock |
Neil A. Schrimsher
|
Director |
Grant, award, or other acquisition of securities at price $ 27.23 per share. |
12 Sep 2022 |
5,326 |
36,000
(0%)
|
0%
|
27.2 |
145,027
|
Common Stock |
Alex N. Blanco
|
Director |
Grant, award, or other acquisition of securities at price $ 27.23 per share. |
12 Sep 2022 |
5,326 |
28,512
(0%)
|
0%
|
27.2 |
145,027
|
Common Stock |
Robert C. Frenzel
|
Director |
Grant, award, or other acquisition of securities at price $ 27.23 per share. |
12 Sep 2022 |
5,326 |
25,454
(0%)
|
0%
|
27.2 |
145,027
|
Common Stock |
Philip G.J. McKoy
|
Director |
Grant, award, or other acquisition of securities at price $ 27.23 per share. |
12 Sep 2022 |
5,326 |
5,326
(0%)
|
0%
|
27.2 |
145,027
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.43 per share. |
07 Aug 2022 |
56 |
99,345
(0%)
|
0%
|
30.4 |
1,704
|
Common Stock |
Timothy E. Rogan
|
President - Dental |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.72 per share. |
19 Jul 2022 |
217 |
45,552
(0%)
|
0%
|
30.7 |
6,666
|
Common Stock |
Timothy E. Rogan
|
President - Dental |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.77 per share. |
14 Jul 2022 |
820 |
45,769
(0%)
|
0%
|
29.8 |
24,411
|
Common Stock |
Donald J. Zurbay
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 29.58 per share. |
06 Jul 2022 |
10,180 |
78,032
(0%)
|
0%
|
29.6 |
301,141
|
Common Stock |
Andrea L. Frohning
|
Chief Human Resources Officer |
Sale of securities on an exchange or to another person at price $ 29.97 per share. |
06 Jul 2022 |
1,986 |
39,259
(0%)
|
0%
|
30.0 |
59,520
|
Common Stock |
Les B. Korsh
|
Chief Legal Officer |
Sale of securities on an exchange or to another person at price $ 29.64 per share. |
06 Jul 2022 |
4,889 |
71,449
(0%)
|
0%
|
29.6 |
144,930
|
Common Stock |
Les B. Korsh
|
Chief Legal Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.59 per share. |
01 Jul 2022 |
4,156 |
73,330
(0%)
|
0%
|
30.6 |
127,132
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2022 |
18,300 |
18,300
|
-
|
|
-
|
Employee Stock Options |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 30.59 per share. |
01 Jul 2022 |
5,312 |
99,401
(0%)
|
0%
|
30.6 |
162,494
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.59 per share. |
01 Jul 2022 |
1,285 |
94,089
(0%)
|
0%
|
30.6 |
39,308
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.59 per share. |
01 Jul 2022 |
3,420 |
95,374
(0%)
|
0%
|
30.6 |
104,618
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.59 per share. |
01 Jul 2022 |
48,492 |
279,804
(0%)
|
0%
|
30.6 |
1,483,370
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.59 per share. |
01 Jul 2022 |
18,938 |
260,866
(0%)
|
0%
|
30.6 |
579,313
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 30.59 per share. |
01 Jul 2022 |
35,551 |
296,417
(0%)
|
0%
|
30.6 |
1,087,505
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2022 |
122,466 |
122,466
|
-
|
|
-
|
Employee Stock Options |
Timothy E. Rogan
|
President - Dental |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.59 per share. |
01 Jul 2022 |
659 |
42,094
(0%)
|
0%
|
30.6 |
20,159
|
Common Stock |
Timothy E. Rogan
|
President - Dental |
Grant, award, or other acquisition of securities at price $ 30.59 per share. |
01 Jul 2022 |
4,495 |
46,589
(0%)
|
0%
|
30.6 |
137,502
|
Common Stock |
Timothy E. Rogan
|
President - Dental |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2022 |
15,484 |
15,484
|
-
|
|
-
|
Employee Stock Options |
Donald J. Zurbay
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.59 per share. |
01 Jul 2022 |
12,294 |
82,461
(0%)
|
0%
|
30.6 |
376,073
|
Common Stock |
Donald J. Zurbay
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.59 per share. |
01 Jul 2022 |
4,669 |
77,792
(0%)
|
0%
|
30.6 |
142,825
|
Common Stock |
Donald J. Zurbay
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 30.59 per share. |
01 Jul 2022 |
10,420 |
88,212
(0%)
|
0%
|
30.6 |
318,748
|
Common Stock |
Donald J. Zurbay
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2022 |
35,895 |
35,895
|
-
|
|
-
|
Employee Stock Options |
Andrea L. Frohning
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 30.59 per share. |
01 Jul 2022 |
4,904 |
41,245
(0%)
|
0%
|
30.6 |
150,013
|
Common Stock |
Andrea L. Frohning
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2022 |
16,892 |
16,892
|
-
|
|
-
|
Employee Stock Options |
Andrea L. Frohning
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.59 per share. |
01 Jul 2022 |
3,585 |
37,897
(0%)
|
0%
|
30.6 |
109,665
|
Common Stock |
Andrea L. Frohning
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.59 per share. |
01 Jul 2022 |
1,556 |
36,341
(0%)
|
0%
|
30.6 |
47,598
|
Common Stock |
Les B. Korsh
|
Chief Legal Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2022 |
16,892 |
16,892
|
-
|
|
-
|
Employee Stock Options |
Les B. Korsh
|
Chief Legal Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.59 per share. |
01 Jul 2022 |
1,896 |
71,434
(0%)
|
0%
|
30.6 |
57,999
|
Common Stock |
Les B. Korsh
|
Chief Legal Officer |
Grant, award, or other acquisition of securities at price $ 30.59 per share. |
01 Jul 2022 |
4,904 |
76,338
(0%)
|
0%
|
30.6 |
150,013
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 24.91 per share. |
30 Jun 2022 |
297 |
328,296
(0%)
|
0%
|
24.9 |
7,399
|
Common Stock |
Les B. Korsh
|
Chief Legal Officer |
Sale of securities on an exchange or to another person at price $ 34.96 per share. |
14 Apr 2022 |
6,000 |
77,486
(0%)
|
0%
|
35.0 |
209,759
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 24.91 per share. |
31 Mar 2022 |
556 |
327,999
(0%)
|
0%
|
24.9 |
13,852
|
Common Stock |
Donald J. Zurbay
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 30.88 per share. |
15 Mar 2022 |
10,000 |
94,755
(0%)
|
0%
|
30.9 |
308,802
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Sale of securities on an exchange or to another person at price $ 30.91 per share. |
15 Mar 2022 |
6,000 |
83,486
(0%)
|
0%
|
30.9 |
185,441
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.00 per share. |
01 Dec 2021 |
719 |
327,443
(0%)
|
0%
|
30 |
21,570
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 29.77 per share. |
30 Sep 2021 |
73 |
98,794
(0%)
|
0%
|
29.8 |
2,173
|
Common Stock |
Ellen A. Rudnick
|
Director |
Grant, award, or other acquisition of securities at price $ 31.86 per share. |
13 Sep 2021 |
4,552 |
65,421
(0%)
|
0%
|
31.9 |
145,027
|
Common Stock |
Jody H. Feragen
|
Director |
Grant, award, or other acquisition of securities at price $ 31.86 per share. |
13 Sep 2021 |
4,552 |
39,031
(0%)
|
0%
|
31.9 |
145,027
|
Common Stock |
John D. Buck
|
Director |
Grant, award, or other acquisition of securities at price $ 31.86 per share. |
13 Sep 2021 |
4,552 |
74,755
(0%)
|
0%
|
31.9 |
145,027
|
Common Stock |
Neil A. Schrimsher
|
Director |
Grant, award, or other acquisition of securities at price $ 31.86 per share. |
13 Sep 2021 |
4,552 |
30,674
(0%)
|
0%
|
31.9 |
145,027
|
Common Stock |
Francis J. Malecha
|
Director |
Grant, award, or other acquisition of securities at price $ 31.86 per share. |
13 Sep 2021 |
4,552 |
20,128
(0%)
|
0%
|
31.9 |
145,027
|
Common Stock |
Alex N. Blanco
|
Director |
Grant, award, or other acquisition of securities at price $ 31.86 per share. |
13 Sep 2021 |
4,552 |
23,186
(0%)
|
0%
|
31.9 |
145,027
|
Common Stock |
Robert C. Frenzel
|
Director |
Grant, award, or other acquisition of securities at price $ 31.86 per share. |
13 Sep 2021 |
4,552 |
20,128
(0%)
|
0%
|
31.9 |
145,027
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.48 per share. |
07 Aug 2021 |
60 |
98,721
(0%)
|
0%
|
29.5 |
1,769
|
Common Stock |
Andrea L. Frohning
|
Chief Human Resources Officer |
Sale of securities on an exchange or to another person at price $ 30.29 per share. |
06 Jul 2021 |
77 |
41,482
(0%)
|
0%
|
30.3 |
2,332
|
Common Stock |
Donald J. Zurbay
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 30.77 per share. |
01 Jul 2021 |
9,750 |
104,755
(0%)
|
0%
|
30.8 |
300,008
|
Common Stock |
Donald J. Zurbay
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.77 per share. |
01 Jul 2021 |
892 |
95,005
(0%)
|
0%
|
30.8 |
27,447
|
Common Stock |
Donald J. Zurbay
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2021 |
37,831 |
37,831
|
-
|
|
-
|
Employee Stock Options |
Andrea L. Frohning
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.77 per share. |
01 Jul 2021 |
155 |
37,090
(0%)
|
0%
|
30.8 |
4,769
|
Common Stock |
Andrea L. Frohning
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 30.77 per share. |
01 Jul 2021 |
4,469 |
41,559
(0%)
|
0%
|
30.8 |
137,511
|
Common Stock |
Andrea L. Frohning
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2021 |
17,339 |
17,339
|
-
|
|
-
|
Employee Stock Options |
Les B. Korsh
|
VP, General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2021 |
17,339 |
17,339
|
-
|
|
-
|
Employee Stock Options |
Les B. Korsh
|
VP, General Counsel |
Grant, award, or other acquisition of securities at price $ 30.77 per share. |
01 Jul 2021 |
4,469 |
89,486
(0%)
|
0%
|
30.8 |
137,511
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.77 per share. |
01 Jul 2021 |
679 |
85,017
(0%)
|
0%
|
30.8 |
20,893
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.77 per share. |
01 Jul 2021 |
664 |
93,906
(0%)
|
0%
|
30.8 |
20,431
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2021 |
18,916 |
18,916
|
-
|
|
-
|
Employee Stock Options |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 30.77 per share. |
01 Jul 2021 |
4,875 |
98,781
(0%)
|
0%
|
30.8 |
150,004
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 30.77 per share. |
01 Jul 2021 |
32,499 |
328,162
(0%)
|
0%
|
30.8 |
999,994
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2021 |
126,103 |
126,103
|
-
|
|
-
|
Employee Stock Options |
Mark S. Walchirk
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.77 per share. |
01 Jul 2021 |
2,958 |
295,663
(0%)
|
0%
|
30.8 |
91,018
|
Common Stock |
Eric R. Shirley
|
President-Patterson Dental |
Grant, award, or other acquisition of securities at price $ 30.77 per share. |
01 Jul 2021 |
3,656 |
55,567
(0%)
|
0%
|
30.8 |
112,495
|
Common Stock |
Eric R. Shirley
|
President-Patterson Dental |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2021 |
14,187 |
14,187
|
-
|
|
-
|
Employee Stock Options |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 24.77 per share. |
30 Jun 2021 |
440 |
94,570
(0%)
|
0%
|
24.8 |
10,898
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 24.77 per share. |
30 Jun 2021 |
391 |
298,621
(0%)
|
0%
|
24.8 |
9,685
|
Common Stock |
Eric R. Shirley
|
President-Patterson Dental |
Grant, award, or other acquisition of securities at price $ 24.77 per share. |
30 Jun 2021 |
150 |
51,911
(0%)
|
0%
|
24.8 |
3,715
|
Common Stock |
Andrea L. Frohning
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.71 per share. |
21 May 2021 |
2,717 |
37,245
(0%)
|
0%
|
34.7 |
94,307
|
Common Stock |
Donald J. Zurbay
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.46 per share. |
24 Apr 2021 |
5,630 |
95,897
(0%)
|
0%
|
33.5 |
188,380
|
Common Stock |
Andrea L. Frohning
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 33.46 per share. |
24 Apr 2021 |
1,712 |
39,962
(0%)
|
0%
|
33.5 |
57,284
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Sale of securities on an exchange or to another person at price $ 33.65 per share. |
24 Apr 2021 |
1,174 |
101,139
(0%)
|
0%
|
33.6 |
39,505
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.46 per share. |
24 Apr 2021 |
2,398 |
102,313
(0%)
|
0%
|
33.5 |
80,237
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.46 per share. |
24 Apr 2021 |
2,026 |
101,606
(0%)
|
0%
|
33.5 |
67,790
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.46 per share. |
24 Apr 2021 |
22,924 |
298,230
(0%)
|
0%
|
33.5 |
767,037
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 24.77 per share. |
31 Mar 2021 |
345 |
103,631
(0%)
|
0%
|
24.8 |
8,545
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 24.77 per share. |
31 Mar 2021 |
467 |
321,153
(0%)
|
0%
|
24.8 |
11,567
|
Common Stock |
Eric R. Shirley
|
President-Patterson Dental |
Grant, award, or other acquisition of securities at price $ 24.77 per share. |
31 Mar 2021 |
118 |
51,761
(0%)
|
0%
|
24.8 |
2,923
|
Common Stock |
Donald J. Zurbay
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 30.10 per share. |
05 Mar 2021 |
6,817 |
101,525
(0%)
|
0%
|
30.1 |
205,173
|
Common Stock |
Jody H. Feragen
|
Director |
Sale of securities on an exchange or to another person at price $ 32.83 per share. |
13 Jan 2021 |
10,052 |
34,479
(0%)
|
0%
|
32.8 |
329,986
|
Common Stock |
Jody H. Feragen
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2021 |
12,000 |
0
|
-
|
|
-
|
Director Stock Options |
Jody H. Feragen
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.36 per share. |
13 Jan 2021 |
12,000 |
44,531
(0%)
|
0%
|
27.4 |
328,320
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.14 per share. |
04 Jan 2021 |
1,352 |
104,711
(0%)
|
0%
|
29.1 |
39,397
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.14 per share. |
04 Jan 2021 |
2,017 |
320,686
(0%)
|
0%
|
29.1 |
58,775
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.70 per share. |
01 Dec 2020 |
720 |
322,703
(0%)
|
0%
|
27.7 |
19,944
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 17.36 per share. |
30 Sep 2020 |
77 |
103,286
(0%)
|
0%
|
17.4 |
1,337
|
Common Stock |
Eric R. Shirley
|
President-Patterson Dental |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Sep 2020 |
24,780 |
24,780
|
-
|
|
-
|
Employee Stock Options |
Eric R. Shirley
|
President-Patterson Dental |
Grant, award, or other acquisition of securities at price $ 17.37 per share. |
30 Sep 2020 |
177 |
51,445
(0%)
|
0%
|
17.4 |
3,074
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.65 per share. |
21 Sep 2020 |
37 |
103,209
(0%)
|
0%
|
24.6 |
912
|
Common Stock |
Ellen A. Rudnick
|
Director |
Grant, award, or other acquisition of securities at price $ 24.66 per share. |
14 Sep 2020 |
4,704 |
60,869
(0%)
|
0%
|
24.7 |
116,001
|
Common Stock |
Jody H. Feragen
|
Director |
Grant, award, or other acquisition of securities at price $ 24.66 per share. |
14 Sep 2020 |
4,704 |
32,531
(0%)
|
0%
|
24.7 |
116,001
|
Common Stock |
John D. Buck
|
Director |
Grant, award, or other acquisition of securities at price $ 24.66 per share. |
14 Sep 2020 |
4,704 |
70,203
(0%)
|
0%
|
24.7 |
116,001
|
Common Stock |
Neil A. Schrimsher
|
Director |
Grant, award, or other acquisition of securities at price $ 24.66 per share. |
14 Sep 2020 |
4,704 |
26,122
(0%)
|
0%
|
24.7 |
116,001
|
Common Stock |
Francis J. Malecha
|
Director |
Grant, award, or other acquisition of securities at price $ 24.66 per share. |
14 Sep 2020 |
4,704 |
15,576
(0%)
|
0%
|
24.7 |
116,001
|
Common Stock |
Alex N. Blanco
|
Director |
Grant, award, or other acquisition of securities at price $ 24.66 per share. |
14 Sep 2020 |
4,704 |
18,634
(0%)
|
0%
|
24.7 |
116,001
|
Common Stock |
Robert C. Frenzel
|
Director |
Grant, award, or other acquisition of securities at price $ 24.66 per share. |
14 Sep 2020 |
4,704 |
15,576
(0%)
|
0%
|
24.7 |
116,001
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Sale of securities on an exchange or to another person at price $ 25.08 per share. |
08 Sep 2020 |
3,111 |
106,063
(0%)
|
0%
|
25.1 |
78,025
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.69 per share. |
07 Aug 2020 |
36 |
103,246
(0%)
|
0%
|
27.7 |
997
|
Common Stock |
Donald J. Zurbay
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 23.57 per share. |
14 Jul 2020 |
11,137 |
108,342
(0%)
|
0%
|
23.6 |
262,499
|
Common Stock |
Donald J. Zurbay
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jul 2020 |
57,819 |
57,819
|
-
|
|
-
|
Employee Stock Options |
Andrea L. Frohning
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jul 2020 |
22,026 |
22,026
|
-
|
|
-
|
Employee Stock Options |
Andrea L. Frohning
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 23.57 per share. |
14 Jul 2020 |
4,243 |
41,673
(0%)
|
0%
|
23.6 |
100,008
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jul 2020 |
24,780 |
24,780
|
-
|
|
-
|
Employee Stock Options |
Les B. Korsh
|
VP, General Counsel |
Grant, award, or other acquisition of securities at price $ 23.57 per share. |
14 Jul 2020 |
4,773 |
109,174
(0%)
|
0%
|
23.6 |
112,500
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jul 2020 |
24,780 |
24,780
|
-
|
|
-
|
Employee Stock Options |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 23.57 per share. |
14 Jul 2020 |
4,773 |
103,282
(0%)
|
0%
|
23.6 |
112,500
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 23.57 per share. |
14 Jul 2020 |
34,472 |
323,423
(0%)
|
0%
|
23.6 |
812,505
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jul 2020 |
178,965 |
178,965
|
-
|
|
-
|
Employee Stock Options |
Eric R. Shirley
|
President-Patterson Dental |
Grant, award, or other acquisition of securities at price $ 23.57 per share. |
14 Jul 2020 |
4,773 |
51,268
(0%)
|
0%
|
23.6 |
112,500
|
Common Stock |
Eric R. Shirley
|
President-Patterson Dental |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jul 2020 |
24,780 |
24,780
|
-
|
|
-
|
Employee Stock Options |
Donald J. Zurbay
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.32 per share. |
01 Jul 2020 |
537 |
63,580
(0%)
|
0%
|
22.3 |
11,986
|
Common Stock |
Donald J. Zurbay
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 22.32 per share. |
01 Jul 2020 |
33,625 |
97,205
(0%)
|
0%
|
22.3 |
750,510
|
Common Stock |
Andrea L. Frohning
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 22.32 per share. |
01 Jul 2020 |
12,810 |
37,430
(0%)
|
0%
|
22.3 |
285,919
|
Common Stock |
Andrea L. Frohning
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.32 per share. |
01 Jul 2020 |
155 |
24,620
(0%)
|
0%
|
22.3 |
3,460
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Grant, award, or other acquisition of securities at price $ 22.32 per share. |
01 Jul 2020 |
14,410 |
104,401
(0%)
|
0%
|
22.3 |
321,631
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Grant, award, or other acquisition of securities at price $ 22.32 per share. |
01 Jul 2020 |
654 |
89,991
(0%)
|
0%
|
22.3 |
14,597
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.32 per share. |
01 Jul 2020 |
463 |
89,337
(0%)
|
0%
|
22.3 |
10,334
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.32 per share. |
01 Jul 2020 |
325 |
82,920
(0%)
|
0%
|
22.3 |
7,254
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 22.32 per share. |
01 Jul 2020 |
1,179 |
84,099
(0%)
|
0%
|
22.3 |
26,315
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 22.32 per share. |
01 Jul 2020 |
14,410 |
98,509
(0%)
|
0%
|
22.3 |
321,631
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 22.32 per share. |
01 Jul 2020 |
5,291 |
184,877
(0%)
|
0%
|
22.3 |
118,095
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 22.32 per share. |
01 Jul 2020 |
104,074 |
288,951
(0%)
|
0%
|
22.3 |
2,322,932
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.32 per share. |
01 Jul 2020 |
1,720 |
179,586
(0%)
|
0%
|
22.3 |
38,390
|
Common Stock |
Eric R. Shirley
|
President-Patterson Dental |
Grant, award, or other acquisition of securities at price $ 22.32 per share. |
01 Jul 2020 |
14,410 |
46,495
(0%)
|
0%
|
22.3 |
321,631
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 17.37 per share. |
30 Jun 2020 |
429 |
83,245
(0%)
|
0%
|
17.4 |
7,450
|
Common Stock |
Eric R. Shirley
|
President-Patterson Dental |
Grant, award, or other acquisition of securities at price $ 17.37 per share. |
30 Jun 2020 |
158 |
32,085
(0%)
|
0%
|
17.4 |
2,744
|
Common Stock |
Donald J. Zurbay
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.50 per share. |
29 Jun 2020 |
3,734 |
64,117
(0%)
|
0%
|
22.5 |
84,015
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.24 per share. |
11 Jun 2020 |
3,752 |
89,800
(0%)
|
0%
|
17.2 |
64,684
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.24 per share. |
11 Jun 2020 |
2,871 |
82,816
(0%)
|
0%
|
17.2 |
49,496
|
Common Stock |
Donald J. Zurbay
|
Chief Financial Officer |
|
25 Apr 2020 |
19,460 |
67,851
(0%)
|
0%
|
|
0
|
Common Stock |
Andrea L. Frohning
|
Chief Human Resources Officer |
|
25 Apr 2020 |
5,838 |
24,775
(0%)
|
0%
|
|
0
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
|
25 Apr 2020 |
8,271 |
93,552
(0%)
|
0%
|
|
0
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
|
25 Apr 2020 |
7,784 |
85,687
(0%)
|
0%
|
|
0
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
|
25 Apr 2020 |
60,330 |
181,306
(0%)
|
0%
|
|
0
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 13.00 per share. |
31 Mar 2020 |
718 |
77,903
(0%)
|
0%
|
13.0 |
9,331
|
Common Stock |
Eric R. Shirley
|
President-Patterson Dental |
Grant, award, or other acquisition of securities at price $ 13.00 per share. |
31 Mar 2020 |
264 |
31,927
(0%)
|
0%
|
13.0 |
3,431
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.43 per share. |
02 Jan 2020 |
676 |
85,281
(0%)
|
0%
|
20.4 |
13,811
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.43 per share. |
02 Jan 2020 |
766 |
77,185
(0%)
|
0%
|
20.4 |
15,649
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 17.08 per share. |
31 Dec 2019 |
64 |
120,976
(0%)
|
0%
|
17.1 |
1,093
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.46 per share. |
01 Dec 2019 |
12,402 |
120,912
(0%)
|
0%
|
19.5 |
241,343
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 15.15 per share. |
30 Sep 2019 |
219 |
77,951
(0%)
|
0%
|
15.1 |
3,317
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 15.15 per share. |
30 Sep 2019 |
433 |
133,314
(0%)
|
0%
|
15.1 |
6,559
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.64 per share. |
21 Sep 2019 |
84 |
77,732
(0%)
|
0%
|
17.6 |
1,482
|
Common Stock |
Ellen A. Rudnick
|
Director |
Grant, award, or other acquisition of securities at price $ 18.71 per share. |
16 Sep 2019 |
6,200 |
56,165
(0%)
|
0%
|
18.7 |
116,002
|
Common Stock |
Jody H. Feragen
|
Director |
Grant, award, or other acquisition of securities at price $ 18.71 per share. |
16 Sep 2019 |
6,200 |
27,827
(0%)
|
0%
|
18.7 |
116,002
|
Common Stock |
John D. Buck
|
Director |
Grant, award, or other acquisition of securities at price $ 18.71 per share. |
16 Sep 2019 |
6,200 |
65,499
(0%)
|
0%
|
18.7 |
116,002
|
Common Stock |
Neil A. Schrimsher
|
Director |
Grant, award, or other acquisition of securities at price $ 18.71 per share. |
16 Sep 2019 |
6,200 |
21,418
(0%)
|
0%
|
18.7 |
116,002
|
Common Stock |
Francis J. Malecha
|
Director |
Grant, award, or other acquisition of securities at price $ 18.71 per share. |
16 Sep 2019 |
6,200 |
10,872
(0%)
|
0%
|
18.7 |
116,002
|
Common Stock |
Alex N. Blanco
|
Director |
Grant, award, or other acquisition of securities at price $ 18.71 per share. |
16 Sep 2019 |
6,200 |
13,930
(0%)
|
0%
|
18.7 |
116,002
|
Common Stock |
Robert C. Frenzel
|
Director |
Grant, award, or other acquisition of securities at price $ 18.71 per share. |
16 Sep 2019 |
6,200 |
10,872
(0%)
|
0%
|
18.7 |
116,002
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.92 per share. |
07 Aug 2019 |
51 |
77,816
(0%)
|
0%
|
17.9 |
914
|
Common Stock |
Andrea L. Frohning
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2019 |
30,030 |
30,030
|
-
|
|
-
|
Employee Stock Options |
Andrea L. Frohning
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.25 per share. |
01 Jul 2019 |
205 |
14,443
(0%)
|
0%
|
22.2 |
4,561
|
Common Stock |
Andrea L. Frohning
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 22.25 per share. |
01 Jul 2019 |
4,494 |
18,937
(0%)
|
0%
|
22.3 |
99,992
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.25 per share. |
01 Jul 2019 |
807 |
80,901
(0%)
|
0%
|
22.3 |
17,956
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Grant, award, or other acquisition of securities at price $ 22.25 per share. |
01 Jul 2019 |
5,056 |
85,957
(0%)
|
0%
|
22.3 |
112,496
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2019 |
33,784 |
33,784
|
-
|
|
-
|
Employee Stock Options |
Eric R. Shirley
|
President-Patterson Dental |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2019 |
33,784 |
33,784
|
-
|
|
-
|
Employee Stock Options |
Eric R. Shirley
|
President-Patterson Dental |
Grant, award, or other acquisition of securities at price $ 22.25 per share. |
01 Jul 2019 |
5,056 |
31,663
(0%)
|
0%
|
22.3 |
112,496
|
Common Stock |
Donald J. Zurbay
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.90 per share. |
29 Jun 2019 |
4,725 |
37,274
(0%)
|
0%
|
22.9 |
108,203
|
Common Stock |
Donald J. Zurbay
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.25 per share. |
29 Jun 2019 |
681 |
36,593
(0%)
|
0%
|
22.2 |
15,152
|
Common Stock |
Donald J. Zurbay
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 22.25 per share. |
29 Jun 2019 |
11,798 |
48,391
(0%)
|
0%
|
22.3 |
262,506
|
Common Stock |
Donald J. Zurbay
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Jun 2019 |
78,829 |
78,829
|
-
|
|
-
|
Employee Stock Options |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Jun 2019 |
33,784 |
33,784
|
-
|
|
-
|
Employee Stock Options |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 17.08 per share. |
28 Jun 2019 |
513 |
72,811
(0%)
|
0%
|
17.1 |
8,760
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 22.25 per share. |
28 Jun 2019 |
5,056 |
77,867
(0%)
|
0%
|
22.3 |
112,496
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Jun 2019 |
243,994 |
243,994
|
-
|
|
-
|
Employee Stock Options |
Mark S. Walchirk
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 22.25 per share. |
28 Jun 2019 |
36,517 |
132,881
(0%)
|
0%
|
22.2 |
812,503
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.25 per share. |
28 Jun 2019 |
2,181 |
96,364
(0%)
|
0%
|
22.2 |
48,527
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 17.08 per share. |
28 Jun 2019 |
374 |
98,545
(0%)
|
0%
|
17.1 |
6,387
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.10 per share. |
11 Jun 2019 |
5,165 |
81,708
(0%)
|
0%
|
22.1 |
114,147
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 17.08 per share. |
29 Mar 2019 |
512 |
72,298
(0%)
|
0%
|
17.1 |
8,743
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 17.08 per share. |
29 Mar 2019 |
373 |
98,171
(0%)
|
0%
|
17.1 |
6,370
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Grant, award, or other acquisition of securities at price $ 14.74 per share. |
02 Jan 2019 |
3,765 |
87,247
(0%)
|
0%
|
14.7 |
55,496
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.09 per share. |
02 Jan 2019 |
374 |
86,873
(0%)
|
0%
|
20.1 |
7,514
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.09 per share. |
02 Jan 2019 |
766 |
71,786
(0%)
|
0%
|
20.1 |
15,389
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 14.74 per share. |
02 Jan 2019 |
5,766 |
97,798
(0%)
|
0%
|
14.7 |
84,991
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.43 per share. |
03 Dec 2018 |
9,200 |
92,032
(0%)
|
0%
|
25.4 |
233,956
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.67 per share. |
21 Sep 2018 |
84 |
72,552
(0%)
|
0%
|
25.7 |
2,156
|
Common Stock |
Ellen A. Rudnick
|
None |
Grant, award, or other acquisition of securities at price $ 24.83 per share. |
17 Sep 2018 |
4,672 |
49,965
(0%)
|
0%
|
24.8 |
116,006
|
Common Stock |
Jody H. Feragen
|
None |
Grant, award, or other acquisition of securities at price $ 24.83 per share. |
17 Sep 2018 |
4,672 |
21,627
(0%)
|
0%
|
24.8 |
116,006
|
Common Stock |
James W. Wiltz
|
None |
Grant, award, or other acquisition of securities at price $ 24.83 per share. |
17 Sep 2018 |
4,672 |
59,465
(0%)
|
0%
|
24.8 |
116,006
|
Common Stock |
John D. Buck
|
None |
Grant, award, or other acquisition of securities at price $ 24.83 per share. |
17 Sep 2018 |
4,672 |
59,299
(0%)
|
0%
|
24.8 |
116,006
|
Common Stock |
Neil A. Schrimsher
|
None |
Grant, award, or other acquisition of securities at price $ 24.83 per share. |
17 Sep 2018 |
4,672 |
15,218
(0%)
|
0%
|
24.8 |
116,006
|
Common Stock |
Francis J. Malecha
|
None |
Grant, award, or other acquisition of securities at price $ 24.83 per share. |
17 Sep 2018 |
4,672 |
4,672
(0%)
|
0%
|
24.8 |
116,006
|
Common Stock |
Alex N. Blanco
|
None |
Grant, award, or other acquisition of securities at price $ 24.83 per share. |
17 Sep 2018 |
4,672 |
7,730
(0%)
|
0%
|
24.8 |
116,006
|
Common Stock |
Robert C. Frenzel
|
None |
Grant, award, or other acquisition of securities at price $ 24.83 per share. |
17 Sep 2018 |
4,672 |
4,672
(0%)
|
0%
|
24.8 |
116,006
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.63 per share. |
07 Aug 2018 |
51 |
72,636
(0%)
|
0%
|
22.6 |
1,154
|
Common Stock |
Andrea L. Frohning
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2018 |
10,009 |
10,009
|
-
|
|
-
|
Employee Stock Options |
Andrea L. Frohning
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 22.48 per share. |
01 Jul 2018 |
3,336 |
14,648
(0%)
|
0%
|
22.5 |
74,993
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Grant, award, or other acquisition of securities at price $ 22.48 per share. |
01 Jul 2018 |
4,726 |
83,482
(0%)
|
0%
|
22.5 |
106,240
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2018 |
14,179 |
14,179
|
-
|
|
-
|
Employee Stock Options |
Les B. Korsh
|
VP, General Counsel |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.48 per share. |
01 Jul 2018 |
502 |
78,756
(0%)
|
0%
|
22.5 |
11,285
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 22.48 per share. |
01 Jul 2018 |
4,448 |
72,687
(0%)
|
0%
|
22.5 |
99,991
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2018 |
13,345 |
13,345
|
-
|
|
-
|
Employee Stock Options |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 19.27 per share. |
01 Jul 2018 |
264 |
68,239
(0%)
|
0%
|
19.3 |
5,087
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.48 per share. |
01 Jul 2018 |
265 |
67,975
(0%)
|
0%
|
22.5 |
5,957
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2018 |
99,956 |
99,956
|
-
|
|
-
|
Employee Stock Options |
Mark S. Walchirk
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 22.48 per share. |
01 Jul 2018 |
35,632 |
101,232
(0%)
|
0%
|
22.5 |
801,007
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Grant, award, or other acquisition of securities at price $ 22.22 per share. |
11 Jun 2018 |
67,506 |
79,258
(0%)
|
0%
|
22.2 |
1,499,983
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 22.22 per share. |
11 Jun 2018 |
56,255 |
68,240
(0%)
|
0%
|
22.2 |
1,249,986
|
Common Stock |
David G. Misiak
|
President, Patterson Dental |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.28 per share. |
30 Apr 2018 |
197 |
12,665
(0%)
|
0%
|
23.3 |
4,586
|
Common Stock |
Dennis Goedken
|
Interim CFO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.28 per share. |
30 Apr 2018 |
107 |
4,440
(0%)
|
0%
|
23.3 |
2,491
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 18.90 per share. |
02 Apr 2018 |
396 |
11,985
(0%)
|
0%
|
18.9 |
7,483
|
Common Stock |
Dennis Goedken
|
Interim CFO |
Grant, award, or other acquisition of securities at price $ 18.90 per share. |
02 Apr 2018 |
262 |
4,547
(0%)
|
0%
|
18.9 |
4,951
|
Common Stock |
Ann B. Gugino
|
Executive Vice President & CFO |
Sale of securities on an exchange or to another person at price $ 36.38 per share. |
11 Jan 2018 |
750 |
32,705
(0%)
|
0%
|
36.4 |
27,285
|
Common Stock |
Ann B. Gugino
|
Executive Vice President & CFO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.88 per share. |
31 Dec 2017 |
411 |
33,455
(0%)
|
0%
|
37.9 |
15,569
|
Common Stock |
Ann B. Gugino
|
Executive Vice President & CFO |
Grant, award, or other acquisition of securities at price $ 27.10 per share. |
31 Dec 2017 |
3,971 |
33,866
(0%)
|
0%
|
27.1 |
107,614
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Grant, award, or other acquisition of securities at price $ 27.10 per share. |
31 Dec 2017 |
1,882 |
11,752
(0%)
|
0%
|
27.1 |
51,002
|
Common Stock |
David G. Misiak
|
President, Patterson Dental |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.88 per share. |
31 Dec 2017 |
300 |
12,862
(0%)
|
0%
|
37.9 |
11,364
|
Common Stock |
David G. Misiak
|
President, Patterson Dental |
Grant, award, or other acquisition of securities at price $ 27.10 per share. |
31 Dec 2017 |
710 |
13,162
(0%)
|
0%
|
27.1 |
19,241
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 27.10 per share. |
31 Dec 2017 |
2,233 |
11,589
(0%)
|
0%
|
27.1 |
60,514
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Dec 2017 |
52,764 |
52,764
|
-
|
|
-
|
Employee Stock Option |
Mark S. Walchirk
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 35.41 per share. |
01 Dec 2017 |
56,481 |
65,600
(0%)
|
0%
|
35.4 |
1,999,992
|
Common Stock |
Mark S. Walchirk
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 35.41 per share. |
01 Dec 2017 |
9,119 |
9,119
(0%)
|
0%
|
35.4 |
322,904
|
Common Stock |
John D. Buck
|
None |
Purchase of securities on an exchange or from another person at price $ 34.93 per share. |
24 Nov 2017 |
2,834 |
54,627
(0%)
|
0%
|
34.9 |
98,992
|
Common Stock |
David G. Misiak
|
President, Patterson Dental |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.12 per share. |
01 Nov 2017 |
58 |
12,452
(0%)
|
0%
|
36.1 |
2,095
|
Common Stock |
Ann B. Gugino
|
Executive Vice President & CFO |
Sale of securities on an exchange or to another person at price $ 36.73 per share. |
11 Oct 2017 |
750 |
29,895
(0%)
|
0%
|
36.7 |
27,548
|
Common Stock |
Kelly A. Baker
|
CHRO |
Grant, award, or other acquisition of securities at price $ 32.86 per share. |
10 Oct 2017 |
105 |
16,298
(0%)
|
0%
|
32.9 |
3,450
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.12 per share. |
21 Sep 2017 |
101 |
9,356
(0%)
|
0%
|
37.1 |
3,749
|
Common Stock |
Ellen A. Rudnick
|
None |
Grant, award, or other acquisition of securities at price $ 37.94 per share. |
18 Sep 2017 |
3,058 |
45,293
(0%)
|
0%
|
37.9 |
116,021
|
Common Stock |
Jody H. Feragen
|
None |
Grant, award, or other acquisition of securities at price $ 37.94 per share. |
18 Sep 2017 |
3,058 |
16,955
(0%)
|
0%
|
37.9 |
116,021
|
Common Stock |
James W. Wiltz
|
None |
Grant, award, or other acquisition of securities at price $ 37.94 per share. |
18 Sep 2017 |
3,058 |
54,793
(0%)
|
0%
|
37.9 |
116,021
|
Common Stock |
John D. Buck
|
None |
Grant, award, or other acquisition of securities at price $ 37.94 per share. |
18 Sep 2017 |
3,058 |
51,793
(0%)
|
0%
|
37.9 |
116,021
|
Common Stock |
Les C. Vinney
|
None |
Grant, award, or other acquisition of securities at price $ 37.94 per share. |
18 Sep 2017 |
3,058 |
33,619
(0%)
|
0%
|
37.9 |
116,021
|
Common Stock |
Neil A. Schrimsher
|
None |
Grant, award, or other acquisition of securities at price $ 37.94 per share. |
18 Sep 2017 |
3,058 |
10,546
(0%)
|
0%
|
37.9 |
116,021
|
Common Stock |
Alex N. Blanco
|
None |
Grant, award, or other acquisition of securities at price $ 37.94 per share. |
18 Sep 2017 |
3,058 |
3,058
(0%)
|
0%
|
37.9 |
116,021
|
Common Stock |
Sarena S. Lin
|
None |
Grant, award, or other acquisition of securities at price $ 37.94 per share. |
18 Sep 2017 |
3,058 |
15,546
(0%)
|
0%
|
37.9 |
116,021
|
Common Stock |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Aug 2017 |
5,539 |
5,539
|
-
|
|
-
|
Employee Stock Options |
Kevin M. Pohlman
|
President - Animal Health |
Grant, award, or other acquisition of securities at price $ 39.23 per share. |
07 Aug 2017 |
955 |
9,457
(0%)
|
0%
|
39.2 |
37,465
|
Common Stock |
Ann B. Gugino
|
Executive Vice President & CFO |
Sale of securities on an exchange or to another person at price $ 42.40 per share. |
11 Jul 2017 |
750 |
30,645
(0%)
|
0%
|
42.4 |
31,800
|
Common Stock |
Scott P. Anderson
|
None |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.51 per share. |
03 Jul 2017 |
2,141 |
98,702
(0%)
|
0%
|
47.5 |
101,719
|
Common Stock |
John E. Adent
|
CEO - Subsidiary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.51 per share. |
03 Jul 2017 |
182 |
1,271
(0%)
|
0%
|
47.5 |
8,647
|
Common Stock |
Ann B. Gugino
|
Executive Vice President & CFO |
Grant, award, or other acquisition of securities at price $ 47.51 per share. |
03 Jul 2017 |
3,972 |
31,395
(0%)
|
0%
|
47.5 |
188,710
|
Common Stock |
Ann B. Gugino
|
Executive Vice President & CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jul 2017 |
21,042 |
21,042
|
-
|
|
-
|
Employee Stock Option |
Ann B. Gugino
|
Executive Vice President & CFO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.51 per share. |
03 Jul 2017 |
942 |
27,423
(0%)
|
0%
|
47.5 |
44,754
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jul 2017 |
11,845 |
11,845
|
-
|
|
-
|
Employee Stock Option |
Les B. Korsh
|
VP, General Counsel |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.51 per share. |
03 Jul 2017 |
530 |
7,634
(0%)
|
0%
|
47.5 |
25,180
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Grant, award, or other acquisition of securities at price $ 47.51 per share. |
03 Jul 2017 |
2,236 |
9,870
(0%)
|
0%
|
47.5 |
106,232
|
Common Stock |
Kelly A. Baker
|
CHRO |
Grant, award, or other acquisition of securities at price $ 47.51 per share. |
03 Jul 2017 |
2,104 |
16,193
(0%)
|
0%
|
47.5 |
99,961
|
Common Stock |
Kelly A. Baker
|
CHRO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jul 2017 |
11,148 |
11,148
|
-
|
|
-
|
Employee Stock Option |
Kelly A. Baker
|
CHRO |
Grant, award, or other acquisition of securities at price $ 36.17 per share. |
03 Jul 2017 |
95 |
14,089
(0%)
|
0%
|
36.2 |
3,436
|
Common Stock |
Kelly A. Baker
|
CHRO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.51 per share. |
03 Jul 2017 |
118 |
13,994
(0%)
|
0%
|
47.5 |
5,606
|
Common Stock |
David G. Misiak
|
President, Patterson Dental |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.51 per share. |
03 Jul 2017 |
727 |
9,879
(0%)
|
0%
|
47.5 |
34,540
|
Common Stock |
David G. Misiak
|
President, Patterson Dental |
Grant, award, or other acquisition of securities at price $ 47.51 per share. |
03 Jul 2017 |
2,631 |
12,510
(0%)
|
0%
|
47.5 |
124,999
|
Common Stock |
David G. Misiak
|
President, Patterson Dental |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jul 2017 |
13,935 |
13,935
|
-
|
|
-
|
Employee Stock Option |
Scott P. Anderson
|
None |
Sale of securities on an exchange or to another person at price $ 46.76 per share. |
14 Jun 2017 |
10,000 |
100,843
(0%)
|
0%
|
46.8 |
467,600
|
Common Stock |
Sarena S. Lin
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.55 per share. |
06 Jun 2017 |
2,000 |
12,488
(0%)
|
0%
|
41.6 |
83,100
|
Common Stock |
Sarena S. Lin
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Jun 2017 |
2,000 |
7,000
|
-
|
|
-
|
Director Stock Options |
Ann B. Gugino
|
Executive Vice President & CFO |
Sale of securities on an exchange or to another person at price $ 43.83 per share. |
30 May 2017 |
750 |
28,365
(0%)
|
0%
|
43.8 |
32,873
|
Common Stock |
Scott P. Anderson
|
Director, Chairman, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.41 per share. |
01 May 2017 |
3,115 |
110,843
(0%)
|
0%
|
44.4 |
138,337
|
Common Stock |
Ann B. Gugino
|
Executive Vice President & CFO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.41 per share. |
01 May 2017 |
630 |
29,115
(0%)
|
0%
|
44.4 |
27,978
|
Common Stock |
David G. Misiak
|
President, Patterson Dental |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.41 per share. |
01 May 2017 |
589 |
10,606
(0%)
|
0%
|
44.4 |
26,157
|
Common Stock |
Scott P. Anderson
|
Director, Chairman, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.58 per share. |
26 Apr 2017 |
2,307 |
113,958
(0%)
|
0%
|
44.6 |
102,846
|
Common Stock |
Ann B. Gugino
|
Executive Vice President & CFO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.58 per share. |
26 Apr 2017 |
270 |
29,745
(0%)
|
0%
|
44.6 |
12,037
|
Common Stock |
David G. Misiak
|
President, Patterson Dental |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.58 per share. |
26 Apr 2017 |
253 |
11,195
(0%)
|
0%
|
44.6 |
11,279
|
Common Stock |
Kelly A. Baker
|
CHRO |
Grant, award, or other acquisition of securities at price $ 36.17 per share. |
06 Apr 2017 |
95 |
14,112
(0%)
|
0%
|
36.2 |
3,436
|
Common Stock |
James W. Wiltz
|
None |
Sale of securities on an exchange or to another person at price $ 45.52 per share. |
15 Mar 2017 |
10,000 |
12,817
(0%)
|
0%
|
45.5 |
455,240
|
Common Stock |
James W. Wiltz
|
None |
Sale of securities on an exchange or to another person at price $ 44.52 per share. |
09 Mar 2017 |
5,000 |
6,748
(0%)
|
0%
|
44.5 |
222,580
|
Common Stock |
Ellen A. Rudnick
|
None |
Sale of securities on an exchange or to another person at price $ 45.70 per share. |
02 Mar 2017 |
3,000 |
42,235
(0%)
|
0%
|
45.7 |
137,100
|
Common Stock |
David G. Misiak
|
President, Patterson Dental |
Sale of securities on an exchange or to another person at price $ 45.57 per share. |
02 Mar 2017 |
301 |
11,448
(0%)
|
0%
|
45.6 |
13,717
|
Common Stock |
James W. Wiltz
|
None |
Sale of securities on an exchange or to another person at price $ 45.65 per share. |
01 Mar 2017 |
10,000 |
22,817
(0%)
|
0%
|
45.7 |
456,517
|
Common Stock |
James W. Wiltz
|
None |
Sale of securities on an exchange or to another person at price $ 45.25 per share. |
27 Feb 2017 |
30,000 |
42,817
(0%)
|
0%
|
45.2 |
1,357,419
|
Common Stock |
James W. Wiltz
|
None |
Sale of securities on an exchange or to another person at price $ 45.45 per share. |
27 Feb 2017 |
5,000 |
37,817
(0%)
|
0%
|
45.5 |
227,250
|
Common Stock |
James W. Wiltz
|
None |
Sale of securities on an exchange or to another person at price $ 45.40 per share. |
27 Feb 2017 |
3,000 |
34,817
(0%)
|
0%
|
45.4 |
136,200
|
Common Stock |
James W. Wiltz
|
None |
Sale of securities on an exchange or to another person at price $ 45.35 per share. |
27 Feb 2017 |
2,000 |
32,817
(0%)
|
0%
|
45.4 |
90,700
|
Common Stock |
Kelly A. Baker
|
CHRO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.92 per share. |
01 Feb 2017 |
1,671 |
14,017
(0%)
|
0%
|
41.9 |
70,048
|
Common Stock |
Scott P. Anderson
|
Director, Chairman, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. |
31 Dec 2016 |
1,220 |
129,831
|
-
|
|
-
|
Common Stock |
Scott P. Anderson
|
Director, Chairman, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Dec 2016 |
2,658 |
131,051
|
-
|
|
-
|
Common Stock |
John Adent
|
CEO - Subsidiary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Dec 2016 |
1,806 |
7,470
|
-
|
|
-
|
Common Stock |
Ann B. Gugino
|
Executive Vice President & CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Dec 2016 |
1,382 |
41,535
|
-
|
|
-
|
Common Stock |
Ann B. Gugino
|
Executive Vice President & CFO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. |
31 Dec 2016 |
346 |
41,189
|
-
|
|
-
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Dec 2016 |
1,039 |
8,501
|
-
|
|
-
|
Common Stock |
David G. Misiak
|
President, Patterson Dental |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. |
31 Dec 2016 |
193 |
11,749
|
-
|
|
-
|
Common Stock |
David G. Misiak
|
President, Patterson Dental |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Dec 2016 |
657 |
11,942
|
-
|
|
-
|
Common Stock |
John D. Buck
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
07 Dec 2016 |
7,500 |
46,235
|
-
|
|
-
|
Common Stock |
John D. Buck
|
None |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
07 Dec 2016 |
2,500 |
48,735
|
-
|
|
-
|
Common Stock |
John D. Buck
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
07 Dec 2016 |
7,500 |
0
|
-
|
|
-
|
Director Stock Options |
John Adent
|
CEO - Subsidiary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Sep 2016 |
33 |
5,664
|
-
|
|
-
|
Common Stock |
John Adent
|
CEO - Subsidiary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. |
21 Sep 2016 |
148 |
5,631
|
-
|
|
-
|
Common Stock |
Jody H. Feragen
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Sep 2016 |
2,534 |
13,897
|
-
|
|
-
|
Common Stock |
James W. Wiltz
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Sep 2016 |
2,534 |
59,387
|
-
|
|
-
|
Common Stock |
Les C. Vinney
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Sep 2016 |
2,534 |
30,561
|
-
|
|
-
|
Common Stock |
John D. Buck
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Sep 2016 |
2,534 |
38,735
|
-
|
|
-
|
Common Stock |
Neil A. Schrimsher
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Sep 2016 |
2,534 |
7,488
|
-
|
|
-
|
Common Stock |
Sarena S. Lin
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Sep 2016 |
2,534 |
10,488
|
-
|
|
-
|
Common Stock |
Ellen A. Rudnick
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Sep 2016 |
2,534 |
45,235
|
-
|
|
-
|
Common Stock |
Ellen A. Rudnick
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Sep 2016 |
5,000 |
42,701
|
-
|
|
-
|
Commmon Stock |
Ellen A. Rudnick
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Sep 2016 |
5,000 |
0
|
-
|
|
-
|
Director Stock Options |
Ann B. Gugino
|
Executive Vice President & CFO |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
29 Aug 2016 |
750 |
40,153
|
-
|
|
-
|
Common Stock |
Scott P. Anderson
|
Director, Chairman, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jul 2016 |
216 |
128,393
|
-
|
|
-
|
Common Stock |
John Adent
|
CEO - Subsidiary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jul 2016 |
98 |
5,779
|
-
|
|
-
|
Common Stock |
Ann B. Gugino
|
Executive Vice President & CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jul 2016 |
216 |
40,903
|
-
|
|
-
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jul 2016 |
216 |
7,462
|
-
|
|
-
|
Common Stock |
Scott P. Anderson
|
Director, Chairman, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. |
06 Jul 2016 |
9,482 |
127,831
|
-
|
|
-
|
Common Stock |
Scott P. Anderson
|
Director, Chairman, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Jul 2016 |
18,832 |
137,313
|
-
|
|
-
|
Common Stock |
Ann B. Gugino
|
Executive Vice President & CFO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. |
06 Jul 2016 |
1,848 |
40,515
|
-
|
|
-
|
Common Stock |
Ann B. Gugino
|
Executive Vice President & CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Jul 2016 |
3,530 |
42,363
|
-
|
|
-
|
Common Stock |
Scott P. Anderson
|
Director, Chairman, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2016 |
68,681 |
68,681
|
-
|
|
-
|
Employee Stock Options |
Scott P. Anderson
|
Director, Chairman, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2016 |
11,605 |
118,481
|
-
|
|
-
|
Common Stock |
Scott P. Anderson
|
Director, Chairman, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. |
01 Jul 2016 |
2,040 |
106,876
|
-
|
|
-
|
Common Stock |
Paul A. Guggenheim
|
President - Subsidiary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. |
01 Jul 2016 |
605 |
90,615
|
-
|
|
-
|
Common Stock |
John Adent
|
CEO - Subsidiary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2016 |
16,789 |
16,789
|
-
|
|
-
|
Employee Stock Options |
John Adent
|
CEO - Subsidiary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2016 |
2,837 |
5,681
|
-
|
|
-
|
Common Stock |
Ann B. Gugino
|
Executive Vice President & CFO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. |
01 Jul 2016 |
707 |
35,480
|
-
|
|
-
|
Common Stock |
Ann B. Gugino
|
Executive Vice President & CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2016 |
19,841 |
19,841
|
-
|
|
-
|
Employee Stock Options |
Ann B. Gugino
|
Executive Vice President & CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2016 |
3,353 |
38,833
|
-
|
|
-
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. |
01 Jul 2016 |
299 |
5,431
|
-
|
|
-
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2016 |
1,754 |
7,185
|
-
|
|
-
|
Common Stock |
Les B. Korsh
|
VP, General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2016 |
10,379 |
10,379
|
-
|
|
-
|
Employee Stock Options |
Kelly A. Baker
|
CHRO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2016 |
1,754 |
15,688
|
-
|
|
-
|
Common Stock |
Kelly A. Baker
|
CHRO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2016 |
10,379 |
10,379
|
-
|
|
-
|
Employee Stock Options |
John Adent
|
CEO - Subsidiary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jun 2016 |
270 |
2,844
|
-
|
|
-
|
Common Stock |
Sarena S. Lin
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
03 Jun 2016 |
1,500 |
7,954
|
-
|
|
-
|
Common Stock |
Sarena S. Lin
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
03 Jun 2016 |
1,500 |
9,000
|
-
|
|
-
|
Director Stock Options |
Les B. Korsh
|
VP, General Counsel |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. |
02 Jun 2016 |
679 |
5,730
|
-
|
|
-
|
Common Stock |
Ann B. Gugino
|
Vice President & CFO |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
31 May 2016 |
750 |
36,187
|
-
|
|
-
|
Common Stock |
Scott P. Anderson
|
Director, Chairman, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. |
02 May 2016 |
3,495 |
108,916
|
-
|
|
-
|
Common Stock |
Paul A. Guggenheim
|
President - Subsidiary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. |
02 May 2016 |
1,523 |
91,220
|
-
|
|
-
|
Common Stock |
Ann B. Gugino
|
Vice President & CFO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. |
02 May 2016 |
660 |
36,937
|
-
|
|
-
|
Common Stock |
Scott P. Anderson
|
Director, Chairman, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. |
29 Apr 2016 |
1,612 |
112,411
|
-
|
|
-
|
Common Stock |
Paul A. Guggenheim
|
President - Subsidiary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. |
29 Apr 2016 |
715 |
92,743
|
-
|
|
-
|
Common Stock |
Ann B. Gugino
|
Vice President & CFO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. |
29 Apr 2016 |
346 |
37,597
|
-
|
|
-
|
Common Stock |
Scott P. Anderson
|
Director, Chairman, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. |
26 Apr 2016 |
1,078 |
114,023
|
-
|
|
-
|
Common Stock |
Scott P. Anderson
|
Director, Chairman, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. |
26 Apr 2016 |
2,337 |
115,101
|
-
|
|
-
|
Common Stock |
Paul A. Guggenheim
|
President - Subsidiary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. |
26 Apr 2016 |
434 |
93,458
|
-
|
|
-
|
Common Stock |
Paul A. Guggenheim
|
President - Subsidiary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. |
26 Apr 2016 |
672 |
93,892
|
-
|
|
-
|
Common Stock |
Ann B. Gugino
|
Vice President & CFO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. |
26 Apr 2016 |
309 |
38,454
|
-
|
|
-
|
Common Stock |
Ann B. Gugino
|
Vice President & CFO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. |
26 Apr 2016 |
511 |
37,943
|
-
|
|
-
|
Common Stock |